Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxapram Versus Placebo in Preterm Newborns: An International Double Blinded Multicenter Randomized Controlled Trial

NCT04430790 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04430790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04430790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxapram Versus Placebo in Preterm Newborns: An International Double Blinded Multicenter Randomized Controlled Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
June 15, 2020
Completion date
May 1, 2034
Enrollment
396 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

apnea of prematurity, respiratory insufficiency